Fig. 1: Neutralization of the SARS-CoV-2 variants D614G, Alpha, Beta and Delta by therapeutic monoclonal antibodies.
From: Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Neutralization curves of monoclonal antibodies. Dose–response analysis of neutralization of the D614G strain and the Alpha, Beta and Delta variants by four therapeutic monoclonal antibodies (bamlanivimab, etesivimab, casirivimab and imdevimab). Data are mean ± s.d. of four independent experiments.
